MicroRNA-365 regulates human cardiac action potential duration
Dena Esfandyari(German Centre for Cardiovascular Research), Stefan Engelhardt(Heidelberg University), Deepak Ramanujam(Technical University of Munich), Thomas Meitinger(Helmholtz Zentrum München), Anna Christina Näger(Technical University of Munich), Tatjana Dorn(TUM Klinikum), Laurenz Grüter(Technical University of Munich), Konstantin Hennis(Ludwig-Maximilians-Universität München), Martin Borggrefe(University of Padua), Andreas Dendorfer(Centre of Experimental Medicine of the Slovak Academy of Sciences), Anne Dueck(German Centre for Cardiovascular Research), Yassine Sassi(Inserm), Stefanie Fenske(Ludwig-Maximilians-Universität München), Hendrik Milting(Heart and Diabetes Center North Rhine-Westphalia), Alessandra Moretti(TUM Klinikum), Ibrahim El‐Battrawy(University Hospitals of the Ruhr-University of Bochum), Petros Avramopoulos(German Centre for Cardiovascular Research), Melanie A. Meier(Technical University of Munich), Christian Hagl(LMU Klinikum), Martin Biel(Ludwig-Maximilians-Universität München), Bio Maria Ghéo Idrissou(German Centre for Cardiovascular Research)
Cited by 37
Related Papers
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
|New England Journal of Medicine|2010|1.2k
A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets
|Nature Genetics|1995|1.1k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
MicroRNAs in the Human Heart
|Circulation|2007|888